3600 results for «300»
3600 results
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
How should I treat ostial left circumflex stenosis?
18 Feb 2025
Watch this webinar on Monday 3 March at 3:00pm (UTC+1) with G. Stankovic, M. Lesiak and F. Burzotta and learn how to evaluate left main 0,0,1 bifurcation lesion in terms of morphology and clinical relevance, and much more!
#2 - How can I minimise paravalvular leak for my TAVI patients?
29 Jun 2021
Watch this PCR Webinar with A. Latib, M. Reardon and L. Sondergaard
How should we use Transcatheter Tricuspid Valve Repair to treat patients with Tricuspid Regurgitation?
02 Nov 2020
PCR Webinar In The Lab with R. Hahn, J. Hausleiter, G. Tarantini and R. Volker
How should we use transcatheter mitral valve repair to treat patients with mitral regurgitation?
10 Jun 2021
Watch the replay of this PCR Webinar with N. Van Mieghem, N. Karam and P. Lurz!
Exclusive #GulfPCR benefits
Don’t forget about your #PCRLV benefits
Discover how #PCRLV is fostering worldwide connections
Stent retrieval using the stiff wire technique with snare
23 Nov 2018
The stiff wire technique for retrieval of a dislodged coronary stent using a stiff angioplasty wire positioned beside the initial stent guidewire. Find out how to do this manoeuvre?
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry
25 Feb 2021
The study aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry.
Authors :
The PCR Tricuspid Focus Group at EuroPCR 2022
02 Jun 2022
During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.
Best wishes from PCR – collaborating with you for a heart-healthy 2024
08 Jan 2024
Jean Fajadet, Bernard Prendergast and William Wijns reflect on 2023’s progress and achievements. As they look forward to 2024 their vision for PCR is clear: continue advancing cardiovascular care through promoting community knowledge, skills and experience sharing.
Evolution of Imaging
18 Jul 2017
Ever since the creation of the X-ray machine by Wilhelm Conrad Röntgen, the imaging technologies and tools has evolved and gained a crucial role in the treatment of cardiovascular diseases. Learn more about the importance of imaging in interventional cardiology.
The effect of eliminating the hydrostatic pressure gradient during fractional flow reserve measurement
09 Feb 2023
Study the case of this 78-year-old male patient to understand why and how HPG may be important when measuring FFR in patients with CAD, as its height may influence the height of different FFR measurements, and, therefore, the patient management.
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
08 Nov 2022
Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.
Author
Pseudoaneurysm after Left Distal Transradial Access
07 Nov 2018
This case concerns a patient presenting with NSTEMI, referred for coronary angiography after cardiac arrest. She complained of a gradually increasing swelling at the puncture site of left distal radial artery 3 months after coronary angiography.
Author
STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes
19 Oct 2020
At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.
Author
MedAlliance SELUTION SLR Receives Second FDA IDE Approval
09 Aug 2022
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA
04 May 2023
